Use and discontinuation of antipsychotic medication in 20 years following a first episode of schizophrenia: results from the OPUS trial.

IF 5.9 2区 医学 Q1 PSYCHIATRY Psychological Medicine Pub Date : 2024-11-18 DOI:10.1017/S0033291724002678
Helene Gjervig Hansen, Helene Speyer, Anne Emilie Stürup, Carsten Hjorthøj, Dost Öngür, Merete Nordentoft, Nikolai Albert
{"title":"Use and discontinuation of antipsychotic medication in 20 years following a first episode of schizophrenia: results from the OPUS trial.","authors":"Helene Gjervig Hansen, Helene Speyer, Anne Emilie Stürup, Carsten Hjorthøj, Dost Öngür, Merete Nordentoft, Nikolai Albert","doi":"10.1017/S0033291724002678","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Short-term exposure to antipsychotics has proven to be beneficial. However, naturalistic studies are lacking regarding the long-term use of antipsychotics. This study aimed to investigate changes in use of antipsychotics over 20 years after a first-episode schizophrenia.</p><p><strong>Methods: </strong>This study is part of the Danish OPUS trial (1998-2000), including 496 participants with first-episode schizophrenia. Participants were reassessed four times over 20 years. The main outcomes were days on medication, redeemed prescriptions of clozapine, psychiatric hospitalizations, and employment.</p><p><strong>Results: </strong>At the 20-year follow-up, an attrition of 71% was detected. In total, 143 out of 496 participated, with 36% (<i>n</i> = 51) in remission-of-psychotic-symptoms-off-medication. The lowest number of days on medication (mean [s.d.], 339 [538] days) was observed in this group over 20 years. Register data on redeemed antipsychotics were available for all trial participants (<i>n</i> = 416). Individuals in treatment with antipsychotics (<i>n</i> = 120) at the 20-year follow-up had spent significantly more days in treatment (5405 [1857] <i>v.</i> 1434 [1819] mean days, <i>p</i> = 0.00) and more had ever redeemed a prescription of clozapine (25% <i>v.</i> 7.8%, <i>p</i> = 0.00) than individuals who had discontinued antipsychotics (<i>n</i> = 296). Further, discontinuers had significantly higher employment at the 20-year follow-up (28.4% <i>v.</i> 12.5%, <i>p</i> = 0.00).</p><p><strong>Conclusion: </strong>In a cohort of individuals with first-episode schizophrenia, 36% were in remission-of-psychotic-symptoms-off-medication. However, high attrition was detected, potentially affecting study results by inflating results from individuals with favorable outcomes. From register data, free from attrition, approximately 30% were in treatment with antipsychotics, and 70% had discontinued antipsychotics. Individuals in treatment had the least favorable outcomes, implying greater illness severity.</p>","PeriodicalId":20891,"journal":{"name":"Psychological Medicine","volume":" ","pages":"1-11"},"PeriodicalIF":5.9000,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11650151/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychological Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1017/S0033291724002678","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Short-term exposure to antipsychotics has proven to be beneficial. However, naturalistic studies are lacking regarding the long-term use of antipsychotics. This study aimed to investigate changes in use of antipsychotics over 20 years after a first-episode schizophrenia.

Methods: This study is part of the Danish OPUS trial (1998-2000), including 496 participants with first-episode schizophrenia. Participants were reassessed four times over 20 years. The main outcomes were days on medication, redeemed prescriptions of clozapine, psychiatric hospitalizations, and employment.

Results: At the 20-year follow-up, an attrition of 71% was detected. In total, 143 out of 496 participated, with 36% (n = 51) in remission-of-psychotic-symptoms-off-medication. The lowest number of days on medication (mean [s.d.], 339 [538] days) was observed in this group over 20 years. Register data on redeemed antipsychotics were available for all trial participants (n = 416). Individuals in treatment with antipsychotics (n = 120) at the 20-year follow-up had spent significantly more days in treatment (5405 [1857] v. 1434 [1819] mean days, p = 0.00) and more had ever redeemed a prescription of clozapine (25% v. 7.8%, p = 0.00) than individuals who had discontinued antipsychotics (n = 296). Further, discontinuers had significantly higher employment at the 20-year follow-up (28.4% v. 12.5%, p = 0.00).

Conclusion: In a cohort of individuals with first-episode schizophrenia, 36% were in remission-of-psychotic-symptoms-off-medication. However, high attrition was detected, potentially affecting study results by inflating results from individuals with favorable outcomes. From register data, free from attrition, approximately 30% were in treatment with antipsychotics, and 70% had discontinued antipsychotics. Individuals in treatment had the least favorable outcomes, implying greater illness severity.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
精神分裂症首次发作后 20 年内抗精神病药物的使用和停药情况:OPUS 试验的结果。
简介事实证明,短期服用抗精神病药物是有益的。然而,有关长期使用抗精神病药物的自然研究却十分缺乏。本研究旨在调查首次出现精神分裂症后 20 年内使用抗精神病药物的变化情况:本研究是丹麦 OPUS 试验(1998-2000 年)的一部分,包括 496 名首发精神分裂症患者。参与者在20年内接受了4次重新评估。主要结果是服药天数、氯氮平处方的兑换情况、精神病住院情况和就业情况:结果:在 20 年的随访中,发现有 71% 的患者流失。在 496 人中,共有 143 人参与,其中 36%(n = 51)的人在停药后精神症状得到缓解。据观察,20 年来,该组患者的服药天数最少(平均[s.d.]为 339 [538] 天)。所有试验参与者(n = 416)都有关于已兑换抗精神病药物的登记数据。在20年的随访中,接受抗精神病药物治疗的患者(n = 120)与停用抗精神病药物的患者(n = 296)相比,接受治疗的天数(5405 [1857] 天v. 1434 [1819] 天的平均值,p = 0.00)明显较多(25%v. 7.8%,p = 0.00),而且有更多的患者曾经兑换过氯氮平处方。此外,在20年的随访中,停药者的就业率明显更高(28.4%对12.5%,P = 0.00):结论:在一组首发精神分裂症患者中,有36%的人在停药后精神症状得到缓解。然而,研究人员发现,减员率很高,这可能会影响研究结果,因为减员率高会夸大结果良好的患者的研究结果。从登记数据来看,在没有自然减员的情况下,约有 30% 的患者正在接受抗精神病药物治疗,70% 的患者已停用抗精神病药物。正在接受治疗的患者的疗效最差,这意味着他们的病情更为严重。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Psychological Medicine
Psychological Medicine 医学-精神病学
CiteScore
11.30
自引率
4.30%
发文量
711
审稿时长
3-6 weeks
期刊介绍: Now in its fifth decade of publication, Psychological Medicine is a leading international journal in the fields of psychiatry, related aspects of psychology and basic sciences. From 2014, there are 16 issues a year, each featuring original articles reporting key research being undertaken worldwide, together with shorter editorials by distinguished scholars and an important book review section. The journal''s success is clearly demonstrated by a consistently high impact factor.
期刊最新文献
Cognitive presentation at psychosis onset through premorbid deterioration and exposure to environmental risk factors. Deconstructing the nature of emotion regulation impairments at the identification, selection, and implementation stages in individuals at clinical high-risk for psychosis. Disrupted functional connectivity of the emotion regulation network in major depressive disorder and its association with symptom improvement: A multisite resting-state functional MRI study. Altered food liking in depression is driven by macronutrient composition. Intermittent theta-burst stimulation with adjunctive D-cycloserine rapidly resolves suicidal ideation and decreases implicit association with death/suicide.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1